Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E23.08 EPS (ttm)6.41 Insider Own0.10% Shs Outstand2.63B Perf Week3.55%
Market Cap390.04B Forward P/E16.37 EPS next Y9.04 Insider Trans-3.54% Shs Float2.63B Perf Month4.06%
Income17.17B PEG4.81 EPS next Q1.48 Inst Own70.80% Short Float0.52% Perf Quarter1.29%
Sales82.73B P/S4.71 EPS this Y0.50% Inst Trans-0.03% Short Ratio1.73 Perf Half Y1.52%
Book/sh23.27 P/B6.36 EPS next Y16.82% ROA11.00% Target Price164.24 Perf Year9.81%
Cash/sh6.84 P/C21.64 EPS next 5Y4.80% ROE28.60% 52W Range109.16 - 157.00 Perf YTD1.41%
Dividend4.04 P/FCF40.05 EPS past 5Y-0.20% ROI17.30% 52W High-5.78% Beta0.70
Dividend %2.73% Quick Ratio1.00 Sales past 5Y2.00% Gross Margin66.30% 52W Low35.51% ATR2.88
Employees132200 Current Ratio1.30 Sales Q/Q3.30% Oper. Margin23.50% RSI (14)63.13 Volatility1.89% 1.71%
OptionableYes Debt/Eq0.45 EPS Q/Q56.20% Profit Margin20.70% Rel Volume0.93 Prev Close145.21
ShortableYes LT Debt/Eq0.41 EarningsJul 16 BMO Payout58.40% Avg Volume7.94M Price147.92
Recom1.90 SMA204.14% SMA501.90% SMA2004.96% Volume7,392,709 Change1.87%
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Jul-14-20 06:42PM  
04:18PM  
08:11AM  
Jul-13-20 06:33PM  
03:50PM  
11:45AM  
11:11AM  
11:02AM  
10:46AM  
09:29AM  
Jul-12-20 04:53PM  
11:25AM  
07:56AM  
Jul-11-20 11:20AM  
Jul-10-20 03:19PM  
01:10PM  
12:49PM  
10:01AM  
09:00AM  
08:12AM  
07:43AM  
Jul-09-20 04:07PM  
03:01PM  
02:10PM  
01:34PM  
12:30PM  
11:44AM  
09:00AM  
07:04AM  
07:00AM  
12:37AM  
Jul-08-20 04:54PM  
04:21PM  
12:10PM  
11:59AM  
11:30AM  
11:25AM  
06:30AM  
Jul-07-20 05:45PM  
11:46AM  
06:00AM  
Jul-06-20 01:11PM  
01:06PM  
12:19PM  
11:58AM  
11:13AM  
08:38AM  
07:56AM  
06:52AM  
06:51AM  
Jul-05-20 07:05PM  
07:21AM  
Jul-03-20 09:31AM  
Jul-02-20 10:03PM  
05:35PM  
04:37PM  
03:30PM  
03:23PM  
01:12PM  
01:02PM  
10:04AM  
09:11AM  
Jul-01-20 09:46AM  
08:26AM  
07:15AM  
06:15AM  
Jun-29-20 05:45PM  
02:06PM  
11:40AM  
Jun-27-20 01:15PM  
Jun-26-20 09:42AM  
09:41AM  
08:16AM  
Jun-25-20 06:19PM  
11:43AM  
07:14AM  
07:02AM  
07:00AM  
03:06AM  
Jun-24-20 05:36PM  
11:05AM  
02:53AM  
02:05AM  
01:43AM  
Jun-23-20 04:43PM  
01:45PM  
11:21AM  
11:05AM  
10:27AM  
10:27AM  
10:08AM  
Jun-20-20 12:11PM  
Jun-19-20 10:33AM  
09:39AM  
Jun-18-20 03:15PM  
12:27PM  
11:40AM  
11:08AM  
10:41AM  
06:39AM  
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has collaboration agreements with Morphic Therapeutic; and Emergent BioSolutions, Inc. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOHNSON & JOHNSON10% OwnerJun 30Buy17.00725,00012,325,0003,670,516Jul 02 04:58 PM
PEREZ WILLIAM DDirectorMar 13Buy127.6950063,84316,030Mar 17 04:24 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Option Exercise90.4419,2241,738,61975,039Feb 25 04:23 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Sale147.9639,2245,803,58335,815Feb 25 04:23 PM
Ullmann Michael HExec VP, General CounselFeb 13Option Exercise0.0020,3260152,697Feb 18 05:03 PM
Wolk Joseph JExec VP, CFOFeb 13Option Exercise0.007,080021,387Feb 18 05:03 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 13Option Exercise0.0015,809065,532Feb 18 05:03 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13Option Exercise0.0022,2310110,559Feb 18 05:03 PM
Decker Robert JController, CAOFeb 13Option Exercise0.001,499013,946Feb 18 05:03 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 13Option Exercise0.00105,6680220,373Feb 18 05:03 PM
Gorsky AlexChairman, CEOFeb 13Option Exercise0.00107,0160496,472Feb 18 05:03 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 13Option Exercise0.0013,747056,496Feb 18 05:03 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 13Option Exercise0.003,692057,259Feb 18 05:03 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 13Option Exercise0.0011,836061,219Feb 18 05:03 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 13Option Exercise0.0039,3810270,900Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 13Option Exercise0.0016,0840115,813Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 03Option Exercise0.0048,3120123,450Feb 04 07:31 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 03Option Exercise0.0038,650058,154Feb 04 07:31 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Option Exercise62.6258,1283,639,975107,511Feb 03 06:28 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Sale149.3958,1288,683,56849,383Feb 03 06:28 PM
Joly HubertDirectorDec 13Buy141.285,000706,3995,000Dec 16 04:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Option Exercise62.622,017126,30551,736Dec 16 05:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Sale141.072,017284,53849,719Dec 16 05:40 PM